{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:38:32Z","timestamp":1792679912155,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009156","name":"Nantong Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["MSZ2023169"],"award-info":[{"award-number":["MSZ2023169"]}],"id":[{"id":"10.13039\/501100009156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clinbiochem.2026.111213","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:35:48Z","timestamp":1790868948000},"page":"111213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Circulating phosphatidylserine as a plasma biomarker for clinical staging and prognostic prediction in Parkinson's disease: A diagnostic validation study"],"prefix":"10.1016","volume":"146","author":[{"given":"Haiqing","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peili","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihai","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111213_bb0005","doi-asserted-by":"crossref","DOI":"10.31083\/j.jin2205132","article-title":"Pain in Parkinson\u2019s disease: pathophysiology, classification and treatment","volume":"22","author":"Cattaneo","year":"2023","journal-title":"J. Integr. Neurosci."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111213_bb0010","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson\u2019s disease","volume":"391","author":"Tanner","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111213_bb0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"The Lancet Neurology."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111213_bb0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research","volume":"23","author":"Simuni","year":"2024","journal-title":"The Lancet Neurology."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111213_bb0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41392-021-00688-z","article-title":"Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"13","key":"10.1016\/j.clinbiochem.2026.111213_bb0030","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1177\/15353702221090454","article-title":"Hyperinflammation, apoptosis, and organ damage","volume":"247","author":"Kuypers","year":"2022","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"7","key":"10.1016\/j.clinbiochem.2026.111213_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2024.01.020","article-title":"Redistribution of the glycocalyx exposes phagocytic determinants on apoptotic cells","volume":"59","author":"Le","year":"2024","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111213_bb0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s42003-023-04558-y","article-title":"Nanoscale imaging of CD47 informs how plasma membrane modifications shape apoptotic cell recognition","volume":"6","author":"Dufour","year":"2023","journal-title":"Commun. Biol."},{"issue":"16","key":"10.1016\/j.clinbiochem.2026.111213_bb0045","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1038\/s44318-024-00151-z","article-title":"Phosphatidylserine enrichment in the nuclear membrane regulates key enzymes of phosphatidylcholine synthesis","volume":"43","author":"Niu","year":"2024","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111213_bb0050","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.E23-09-0354","article-title":"Lipid- and phospho-regulation of CTP:phosphocholine cytidylyltransferase \u03b1 association with nuclear lipid droplets","volume":"35","author":"Foster","year":"2024","journal-title":"Mol. Biol. Cell"},{"issue":"14","key":"10.1016\/j.clinbiochem.2026.111213_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2023.05.008","article-title":"Apoptotic extracellular vesicle formation via local phosphatidylserine exposure drives efficient cell extrusion","volume":"58","author":"Kira","year":"2023","journal-title":"Dev. Cell"},{"issue":"11","key":"10.1016\/j.clinbiochem.2026.111213_bb0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tcb.2015.08.003","article-title":"An apoptotic \u2018eat me\u2019 signal: phosphatidylserine exposure","volume":"25","author":"Segawa","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.clinbiochem.2026.111213_bb0065","first-page":"472","article-title":"Apoptotic vesicles ameliorate lupus and arthritis via phosphatidylserine-mediated modulation of T cell receptor signaling","volume":"25","author":"Wang","year":"2023","journal-title":"Bioact. Mater."},{"issue":"7","key":"10.1016\/j.clinbiochem.2026.111213_bb0070","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.1021\/jacs.4c14394","article-title":"Copper chelate targeting externalized phosphatidylserine inhibits PD-L1 expression and enhances Cancer immunotherapy","volume":"147","author":"Gao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111213_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100661","article-title":"Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson\u2019s disease","volume":"3","author":"Karayel","year":"2022","journal-title":"Cell reports Medicine."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111213_bb0080","first-page":"139","article-title":"[new diagnostic criteria for Parkinson\u2019s disease: MDS-PD criteria]. Brain and nerve =","volume":"70","author":"Watanabe","year":"2018","journal-title":"Shinkei kenkyu no shinpo."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111213_bb0085","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mds.22875","article-title":"Progression of Parkinson\u2019s disease as evaluated by Hoehn and Yahr stage transition times","volume":"25","author":"Zhao","year":"2010","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111213_bb0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1590\/1980-57642018dn13-010008","article-title":"Montreal cognitive assessment scale in patients with Parkinson disease with normal scores in the Mini-mental state examination","volume":"13","author":"V\u00e1squez","year":"2019","journal-title":"Dementia & Neuropsychologia"},{"issue":"10","key":"10.1016\/j.clinbiochem.2026.111213_bb0095","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/mds.25924","article-title":"People with Parkinson\u2019s disease and normal MMSE score have a broad range of cognitive performance","volume":"29","author":"Burdick","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clinbiochem.2026.111213_bb0100","article-title":"Brief psychiatric screening questionnaire in Parkinson\u2019s disease","volume":"2019","author":"Lee","year":"2019","journal-title":"Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111213_bb0105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1590\/0004-282x-anp-2021-0219","article-title":"Guidelines for Parkinson\u2019s disease treatment: consensus from the movement disorders scientific Department of the Brazilian Academy of neurology - motor symptoms","volume":"80","author":"Saba","year":"2022","journal-title":"Arq. Neuropsiquiatr."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111213_bb0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1877718X241302337","article-title":"Estimation of and clinical consensus on the meaningful motor progression threshold on MDS-UPDRS part III","volume":"15","author":"Trundell","year":"2025","journal-title":"J. Parkinsons Dis."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111213_bb0115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.rehab.2019.08.006","article-title":"Barthel index and modified Rankin scale: psychometric properties during medication phases in idiopathic Parkinson disease","volume":"63","author":"Taghizadeh","year":"2020","journal-title":"Ann. Phys. Rehabil. Med."},{"issue":"11","key":"10.1016\/j.clinbiochem.2026.111213_bb0120","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1007\/s12035-024-04111-w","article-title":"Parkinson\u2019s disease and MicroRNAs: a duel between inhibition and stimulation of apoptosis in neuronal cells","volume":"61","author":"Saadh","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111213_bb0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1566524022666220203163631","article-title":"An insight into the molecular mechanism of mitochondrial toxicant-induced neuronal apoptosis in Parkinson\u2019s disease","volume":"23","author":"Brahadeeswaran","year":"2023","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.clinbiochem.2026.111213_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112361","article-title":"Astragaloside IV- and nesfatin-1-encapsulated phosphatidylserine liposomes conjugated with wheat germ agglutinin and leptin to activate anti-apoptotic pathway and block phosphorylated tau protein expression for Parkinson\u2019s disease treatment","volume":"129","author":"Kuo","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"10","key":"10.1016\/j.clinbiochem.2026.111213_bb0135","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.clinbiochem.2026.111213_bb0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuroscience.2015.08.063","article-title":"Brain metabolic abnormalities during gait with freezing in Parkinson\u2019s disease","volume":"307","author":"Tard","year":"2015","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111213_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.clinbiochem.2026.111213_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.702639","article-title":"Alpha-synuclein as a biomarker of Parkinson\u2019s disease: good, but not good enough","volume":"13","author":"Ganguly","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.clinbiochem.2026.111213_bb0155","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/mds.28206","article-title":"Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression","volume":"35","author":"Mollenhauer","year":"2020","journal-title":"Movement disorders\u202f: official journal of the Movement Disorder Society."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111213_bb0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12883-024-03642-y","article-title":"Associations of sleep disorders with serum neurofilament light chain levels in Parkinson\u2019s disease","volume":"24","author":"Qi","year":"2024","journal-title":"BMC Neurol."},{"issue":"11","key":"10.1016\/j.clinbiochem.2026.111213_bb0165","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer\u2019s disease","volume":"11","author":"Stern","year":"2012","journal-title":"The Lancet Neurology."},{"issue":"8","key":"10.1016\/j.clinbiochem.2026.111213_bb0170","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1002\/alz.13844","article-title":"Sex and gender differences in cognitive resilience to aging and Alzheimer\u2019s disease","volume":"20","author":"Arenaza-Urquijo","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.clinbiochem.2026.111213_bb0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis -an updated review","volume":"71","author":"Alqahtani","year":"2023","journal-title":"Mitochondrion"},{"issue":"Suppl. 1","key":"10.1016\/j.clinbiochem.2026.111213_bb0180","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.clinbiochem.2026.111213_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.970925","article-title":"The neuroprotective effects of glucagon-like peptide 1 in Alzheimer\u2019s and Parkinson\u2019s disease: an in-depth review","volume":"16","author":"Reich","year":"2022","journal-title":"Front. Neurosci."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026001463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026001463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:45:54Z","timestamp":1792676754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912026001463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"alternative-id":["S0009912026001463"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111213","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating phosphatidylserine as a plasma biomarker for clinical staging and prognostic prediction in Parkinson's disease: A diagnostic validation study","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"111213"}}